Michael Driscoll Toboni MD MPH
Gynecologic Oncology
Assistant Professor
Join to view full profile
619 19th St SBirmingham, AL 35249
Phone+1 205-731-9701
Dr. Toboni is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Alabama Hospital (Birmingham)Residency, Obstetrics and Gynecology, 2015 - 2019
Keck School of Medicine of the University of Southern CaliforniaClass of 2015
Certifications & Licensure
AL State Medical License 2016 - 2026
MO State Medical License 2019 - 2023
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma Start of enrollment: 2023 Aug 20
- Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma Start of enrollment: 2023 Apr 18
- Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma Start of enrollment: 2022 Nov 16
Publications & Presentations
PubMed
- A phase II study in newly diagnosed stage III/IV epithelial ovarian cancer evaluating carboplatin/taxol/pembrolizumab in patients receiving neoadjuvant chemotherapy fo...Carson C Edwards, Kati A Turner, Kaitlyn G Dinkins, Peter W Ketch, Anna B Wilbanks
Gynecologic Oncology. 2026-09-21 - Residential Context and Survival Disparities in Black and White Women With Ovarian Cancer.Francesmary Modugno, Emily O'Brien, Chao Cai, Lauren Borho, Austin Hicks
JAMA Network Open. 2026-08-03 - A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma.Kati A Turner, Carson C Edwards, Peter W Ketch, Kaitlyn G Dinkins, Anna Wilbanks
Gynecologic Oncology. 2026-06-01
Press Mentions
Signatera™ Surveillance Testing Identified 100% of Uterine Cancer Recurrences in Advance of Imaging, New Study ShowsSeptember 29th, 2025- The Power of Shared Purpose: Transforming Gynecologic Cancer CareMarch 26th, 2024
- Where Women Live May Influence Ovarian Cancer Survival, Especially Among Black WomenAugust 11th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
